Education
About Us
Working with TipRanks
Follow Us
QQEW - ETF AI Analysis
Top Page
First Trust Nasdaq-100 Equal Weighted Index Fund (QQEW)
Rating:74Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, especially in chip and medical technology companies, have shown strong year-to-date gains that support the fund’s overall results.
Equal-Weighted Nasdaq-100 Exposure
Because each stock has a similar weight, the ETF avoids relying too heavily on a few mega-cap names and gives more balanced exposure across its holdings.
Focused but Varied Sector Mix
While technology is the main driver, the fund also holds meaningful stakes in health care, communication services, and consumer companies, which can help spread risk across different parts of the economy.
Negative Factors
Recent Weak Performance
The ETF has delivered weak returns over the past month, three months, and year-to-date, which may concern investors looking for near-term strength.
High Technology Concentration
With more than half of the portfolio in technology stocks, the fund is highly sensitive to swings in the tech sector.
Higher Expense Ratio
The fund’s expense ratio is relatively high for an index-based ETF, which means more of the return is eaten up by fees compared with lower-cost alternatives.
QQEW vs. SPDR S&P 500 ETF (SPY)
AUM1.71B
RegionNorth America
Expense Ratio0.55%
Beta1.10
IssuerFirst Trust
Inception DateApr 19, 2006
Dividend Yield0.44%
Asset ClassEquity
Index TrackedNasdaq-100 Select Equal Weight Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume44,154
30 Day Avg. Volume45,898
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
173.27Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QQEW Summary
QQEW is an ETF that tracks the Nasdaq-100 Select Equal Weight Index, which means it invests in the 100 major Nasdaq companies but gives each stock roughly the same weight instead of letting the biggest ones dominate. It holds many well-known names such as Advanced Micro Devices (AMD) and ASML, with a strong tilt toward technology, plus health care and communication services. Someone might invest in QQEW to seek growth from leading innovative companies while spreading their money more evenly across them. A key risk is that it is heavily tied to tech-related stocks, so its price can swing a lot with that sector.
How much will it cost me?The ETF QQEW has an expense ratio of 0.55%, which means you’ll pay $5.50 per year for every $1,000 invested. This is higher than average for ETFs because it uses an equal-weighting strategy, which requires more active management compared to passively managed funds that track market-cap-weighted indices.
What would affect this ETF?QQEW's focus on the Nasdaq-100 with an equal-weight strategy provides exposure to a diverse range of large-cap companies, particularly in the technology sector, which could benefit from continued innovation and demand for tech solutions. However, its heavy reliance on technology and consumer sectors makes it vulnerable to economic slowdowns, regulatory changes, or rising interest rates that could negatively impact growth stocks. Additionally, its U.S.-centric exposure may limit gains if international markets outperform or if domestic economic conditions weaken.
QQEW Top 10 Holdings
QQEW’s story right now is all about chip and AI infrastructure names setting the pace. Western Digital, Lam Research, ASML, and KLA have been rising together, giving the fund a strong tailwind from the semiconductor supply chain. AMD and Monolithic Power are also contributing, though their gains look a bit more measured, suggesting some investors are catching their breath after a big run. Health-care names like Dexcom, Amgen, and Gilead are more of a steady ballast than a rocket booster, and the fund remains heavily U.S.-focused and firmly tech-centric.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Western Digital | 3.46% | $59.53M | $100.55B | 299.31% | 77 Outperform | |
| ASML Holding | 3.04% | $52.31M | $559.08B | 96.33% | 81 Outperform | |
| Lam Research | 3.03% | $52.18M | $299.82B | 166.67% | 77 Outperform | |
| Monolithic Power | 2.76% | $47.48M | $56.93B | 70.37% | 75 Outperform | |
| Gilead Sciences | 2.68% | $46.04M | $189.50B | 37.34% | 78 Outperform | |
| KLA | 2.60% | $44.68M | $194.03B | 89.02% | 77 Outperform | |
| Amgen | 2.52% | $43.43M | $204.70B | 26.04% | 77 Outperform | |
| ARM Holdings PLC ADR | 2.45% | $42.15M | $135.13B | -15.86% | 69 Neutral | |
| T Mobile US | 2.41% | $41.44M | $234.97B | -18.88% | 76 Outperform | |
| Dexcom | 2.41% | $41.42M | $28.02B | -19.11% | 79 Outperform |
QQEW Technical Analysis
Negative
―
Price Trends
140.56
Negative
141.04
Negative
137.82
Negative
Market Momentum
-2.52
Positive
38.72
Neutral
43.13
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QQEW, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 136.87, equal to the 50-day MA of 140.56, and equal to the 200-day MA of 137.82, indicating a bearish trend. The MACD of -2.52 indicates Positive momentum. The RSI at 38.72 is Neutral, neither overbought nor oversold. The STOCH value of 43.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QQEW.
QQEW Peer Comparison
Comparison Results
Performance Comparison
QQEW
First Trust Nasdaq-100 Equal Weighted Index Fund
132.80
0.82
0.62%
MGC
Vanguard Mega Cap ETF
―
―
―
PRF
Invesco FTSE RAFI US 1000 ETF
―
―
―
QQQI
NEOS Nasdaq 100 High Income ETF
―
―
―
FTCS
First Trust Capital Strength ETF
―
―
―
QYLD
Global X NASDAQ 100 Covered Call ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents